RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Stock-based compensation

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Jun 30, 202592+14.31%
Jun 30, 202480+12.71%
Jun 30, 202371+9.02%
Jun 30, 202265+2.08%
Jun 30, 202164+11.06%
Jun 30, 202058+10.54%
Jun 30, 201952+7.56%
Jun 30, 201848+5.42%
Jun 30, 201746-1.04%
Jun 30, 201646-3.02%
Jun 30, 201548+10.12%
Jun 30, 201443+13.89%
Jun 30, 201338+24.75%
Jun 30, 201231-0.72%
Jun 30, 201131

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)